New machine may help 'Marginal' donor livers work better after transplant
NCT ID NCT03929523
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a device that pumps cold, oxygenated fluid through donor livers before transplant. The goal was to see if it reduces early organ damage in livers from older or higher-risk donors. 266 liver transplant patients took part. The approach could help more people get successful transplants by improving the quality of donated organs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Hypothermic Oxygenated Machine Perfusion (HOPE) device
- What this could lead to
- If it works, this could reduce early liver damage after transplant, helping more patients get successful transplants from older or higher-risk donors.
- What could go wrong
- This is a completed trial, but results may not apply to all transplant centers or donor types. The device adds time and complexity to the transplant process.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHP - Pitié Salpétrière
Paris, 75013, France
-
CHU Grenoble Alpes - Department of HPB surgery and liver transplantation
Grenoble, 38000, France
-
Department of HPB surgery and liver transplantation Beaujon University Hospital
Clichy, 92210, France
-
Department of HPB surgery and liver transplantation Claude Huriez University Hospital
Lille, 59037, France
-
Department of HPB surgery and liver transplantation Paul Brousse University Hospital
Villejuif, 94804, France
-
Department of HPB surgery and liver transplantation Pontchaillou University Hospital
Rennes, 35033, France
-
Hospices Civils de Lyon
Lyon, 69004, France
-
Hôpital Hautepierre - Department of HPB surgery and liver transplantation
Strasbourg, 67200, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells predict herpesvirus danger in transplant patients?
- Muscle quality on MRI may foretell liver transplant success
- A new Anti-Rejection strategy may spare kidney function after liver transplant
- Can a cell test free liver transplant patients from lifelong drugs?
- Better crystal ball for liver crisis: new scores put to the test
- Smartphone messages may boost medication adherence after liver transplant